Original Article

Whole Exome Sequencing of Chronic Myeloid Leukemia Patients

Abstract

Background: Previous studies have shown that leukemogenic chromosomal translocations, including fusions between Break point Cluster Region (BCR) and Abelson (ABL) are present in the peripheral blood of healthy individuals. The aim of this study was to gain insights into the genetic alterations other than BCR-Abl translocation in molecular level, which cause chronic myeloid leukemia (CML).

Methods: We performed whole-exome sequencing on four cases representative of BCR-ABL positive CML in chronic phase of the disease.

Results: We did not identify any pathogenic mutation in all known genes involved in CML or other cancers in our subjects. Nevertheless, we identified polymorphisms in related genes.

Conclusion: It is the first report of exome sequencing in Philadelphia chromosome positive CML patients. We did not identify any pathogenic mutation in known cancer genes in our patients who can be due to CML pathogenesis or technical limitations.

 

 

Daley GQ (2004). Chronic myeloid leukemia: proving ground for cancer stem cells. Cell, 29, 119(3): 314-6.

Jabbour E1, Fava C, Kantarjian H (2009). Ad¬vances in the biology and therapy of pa¬tients with chronic myeloid leukaemia. Best Pract Res Clin Haematol, 22(3): 395-407.

J. Zhao and S. Grant (2011). Advances in whole genome sequencing technology. Curr Pharm Biotechnol, 12(2):293-305.

M. Meyerson, S. Gabriel, and G. Getz (2010). Advances in understanding cancer genomes through second-generation sequencing. Nature Rev Genet, 10, 685–696.

Piazza R1, Valletta S, Winkelmann N, Redaelli S, Spinelli R, Pirola A, Antolini L, Mologni L, Donadoni C, Papaemmanuil E et al. (2013). Recurrent SETBP1 mutations in atypical chronic myeloid leukemia. Nat Genet, 45(1):18-24.

Peter D. Aplan (2006). Causes of oncogenic chromosomal translocation. Trends Genet, 22(1): 46–55.

D M Ross, M O'Hely, P A Bartley, P Dang, J Score, J M Goyne, M Sobrinho-Simoes, N C P Cross, J V Melo, T P Speed, T P Hughes and A A Morley (2013). Distribution of genomic breakpoints in chronic myeloid leukemia: analysis of 308 patients. Leukemia, 27(10):2105-7.

Janz S, Potter M, Rabkin CS (2003). Lymphoma- and leukemia-associated chromosomal translocations in healthy individuals. Genes Chromosomes Cancer, 36 (3):211–223.

Mori H, Colman SM, Xiao Z, Ford AM, Healy LE, Donaldson C, Hows JM, Navarrete C, Greaves M (2002). Chromosome translocations and covert leukemic clones are generated during normal fetal development. Proc Natl Acad Sci, 99(12):8242–8247.

Izraeli S, Waldman D (2004). Minimal residual disease in childhood acute lymphoblastic leukemia: current status and challenges. Acta Haematol, 112 (1–2):34–39.

Kim DHD, Sriharsha L, Xu W, Kamel-Reid S, Liu X, Siminovitch K, Messner HA, Lipton JH (2009). Clinical relevance of a pharmacogenetic approach using multiple candidate genes to predict response and resistance to imatinib therapy in chronic myeloid leukemia. Clin Cancer Res, 15(14):4750–4758.

Singh O, Chan JY, Lin K, Heng CCT, Chowbay B (2012) SLC22A1-ABCB1 Haplotype Profiles Predict Imatinib Pharmacokinetics in Asian Patients with Chronic Myeloid Leukemia. PLoS ONE, 7(12): e51771.

Shah SP, Köbel M, Senz J, Morin RD, Clarke BA, Wiegand KC, Leung G, Zayed A, Mehl E, Kalloger SE et al. (2009). Mutation of FOXL2 in granulosa-cell tumors of the ovary. N Engl J Med, 360:2719–2729.

Tiacci E, Trifonov V, Schiavoni G, Holmes A, Kern W, Martelli MP, Pucciarini A, Bigerna B, Pacini R, Wells VA et al (2011). BRAF mutations in hairy-cell leukemia. N Engl J Med, 364:2305–2315.

Mardis ER, Ding L, Dooling DJ, Larson DE, McLellan MD, Chen K, Koboldt DC, Fulton RS, Delehaunty KD, McGrath SD et al. (2009). Recurring mutations found by sequencing an acute myeloid leukemia ge¬nome. N Engl J Med, 361:1058–1066.

Coonrod EM, DurtschiJd Fau - Margraf RL, Mar¬grafRl Fau, Voelkerding KV (2013). Develop¬ing genome and exome sequencing for candi¬date gene identification in inherited disorders: an integrated technical and bioinformatics ap-proach. Arch Pathol Lab Med, 137(3):415-33.

Files
IssueVol 45 No 3 (2016) QRcode
SectionOriginal Article(s)
Keywords
CML Whole exome sequencing Iran

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
SABRI S, KEYHANI M, AKBARI MT. Whole Exome Sequencing of Chronic Myeloid Leukemia Patients. Iran J Public Health. 2016;45(3):346-352.